//
The Amnion Foundation Inc. is a private corporation based in WINSTON SALEM, NC. The foundation received its IRS ruling in 2020. The principal officer is % Anthony Atala. It holds total assets of $240K. Annual income is reported at $362K. THROUGH THE END OF 2015, THE AMNION FOUNDATION HAD DEVELOPED A DETAILED PLAN TO BUILD A PUBLIC STEM CELL BANK. IN 2016, THE FOUNDATION SHIFTED INTO EXECUTION MODE, COMPLETING THE BUILD OUT OF ITS CLEANROOM AND BANKING FACILITY, HIRING IT'S FIRST TECHNICIAN, AND AN EXECUTIVE DIRECTOR. THE FOUNDATION ALSO BEGAN TO ASSEMBLE THE APPROPRIATE QUALITY ASSURANCE INFRASTRUCTURE TO ALLOW FDA COMPLIANT TISSUE BANKING PROCESSES. BY THE END OF 2016, THE FOUNDATION WAS RECEIVING THE FIRST TISSUE SAMPLES FOR TRAINING PURPOSES AND REGULATORY VALIDATION RUNS. THIS POSITIONS THE FOUNDATION TO BEGIN BANKING TISSUES FOR HUMAN CLINICAL USE IN 2017. THE FOUNDATION CONTINUED THESE OPERATIONS THROUGH 2018, 2019, 2020, 2021, AND 2022. Contributions to this foundation are tax-deductible.
THROUGH THE END OF 2015, THE AMNION FOUNDATION HAD DEVELOPED A DETAILED PLAN TO BUILD A PUBLIC STEM CELL BANK. IN 2016, THE FOUNDATION SHIFTED INTO EXECUTION MODE, COMPLETING THE BUILD OUT OF ITS CLEANROOM AND BANKING FACILITY, HIRING IT'S FIRST TECHNICIAN, AND AN EXECUTIVE DIRECTOR. THE FOUNDATION ALSO BEGAN TO ASSEMBLE THE APPROPRIATE QUALITY ASSURANCE INFRASTRUCTURE TO ALLOW FDA COMPLIANT TISSUE BANKING PROCESSES. BY THE END OF 2016, THE FOUNDATION WAS RECEIVING THE FIRST TISSUE SAMPLES FOR TRAINING PURPOSES AND REGULATORY VALIDATION RUNS. THIS POSITIONS THE FOUNDATION TO BEGIN BANKING TISSUES FOR HUMAN CLINICAL USE IN 2017. THE FOUNDATION CONTINUED THESE OPERATIONS THROUGH 2018, 2019, AND 2020.
Expenses: $972K
THROUGH THE END OF 2015, THE AMNION FOUNDATION HAD DEVELOPED A DETAILED PLAN TO BUILD A PUBLIC STEM CELL BANK. IN 2016, THE FOUNDATION SHIFTED INTO EXECUTION MODE, COMPLETING THE BUILD OUT OF ITS CLEANROOM AND BANKING FACILITY, HIRING IT'S FIRST TECHNICIAN, AND AN EXECUTIVE DIRECTOR. THE FOUNDATION ALSO BEGAN TO ASSEMBLE THE APPROPRIATE QUALITY ASSURANCE INFRASTRUCTURE TO ALLOW FDA COMPLIANT TISSUE BANKING PROCESSES. BY THE END OF 2016, THE FOUNDATION WAS RECEIVING THE FIRST TISSUE SAMPLES FOR TRAINING PURPOSES AND REGULATORY VALIDATION RUNS. THIS POSITIONS THE FOUNDATION TO BEGIN BANKING TISSUES FOR HUMAN CLINICAL USE IN 2017. THE FOUNDATION CONTINUED THESE OPERATIONS THROUGH 2018, 2019, 2020, 2021, AND 2022.
The Amnion Foundation Inc. typically selects its grantees rather than accepting unsolicited proposals.
The Amnion Foundation Inc. is headquartered in WINSTON SALEM, NC.
| Name | Title | Compensation | Benefits | Total |
|---|---|---|---|---|
| Dr Athony Atala | DIRECTOR | $0 | $0 | $0 |
| Roger Defillipo | DIRECTOR | $0 | $0 | $0 |
| Alan Retick | DIRECTOR | $0 | $0 | $0 |
Total Giving
$651K
Total Assets
$496K
Fair Market Value
$496K
Net Worth
$491K
Grants Paid
$0
Contributions
$1K
Net Investment Income
$0
Distribution Amount
$0
© 2026 Granted AI